MPWT
LBRX

MassMutual Private Wealth & Trust’s LB Pharmaceuticals LBRX Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio LBRX Stock Details LBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.75K Hold
54
– – ﹤0.01% 2040
2026
Q1 		$1.33K Buy
+54
New +$1.25K ﹤0.01% 2075

Other funds holding LBRX

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
LF
Longbow Finance Lutry, Switzerland $782M AUM 48.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MHC
Meyer Handelman Company Rye Brook, New York $3.53B AUM 30.49% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

MassMutual Private Wealth & Trust's LBRX Position: Q2 2026 in Review

MassMutual Private Wealth & Trust held its LB Pharmaceuticals (LBRX) position steady in Q2 2026 at 54 shares worth $1.75K. The position accounts for ﹤0.01% of the portfolio, ranked #2040.

MassMutual Private Wealth & Trust first reported a position in LBRX in Q1 2026 and has held it in 2 quarters since. 13 funds tracked by Wall St. Rank hold LBRX as of Q2 2026.

  • MassMutual Private Wealth & Trust held 54 shares of LB Pharmaceuticals worth $1.75K as of Q2 2026.
  • MassMutual Private Wealth & Trust left its LB Pharmaceuticals share count unchanged in Q2 2026.
  • LB Pharmaceuticals made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #2040 holding.
  • MassMutual Private Wealth & Trust first reported a position in LB Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 13 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.